Sacral neuromodulation for the treatment of refractory interstitial cystitis: outcomes based on technique.

Int Urogynecol J Pelvic Floor Dysfunct

Department of Urology, William Beaumont Hospital, 3535 West 13 Mile Rd., Suite 438, Royal Oak, MI 48073, USA.

Published: October 2003

Patients with refractory interstitial cystitis (IC) underwent testing with sacral nerve modulation via either a traditional percutaneous approach or a staged procedure. Implanted patients were followed with scaled questionnaires and voiding diaries. Twenty-six patients who had a permanent InterStim placed had a reduction in 24-h voids of 51%. More than two-thirds of patients reported a moderate or marked improvement in urinary frequency, urgency, pelvic pain, pelvic pressure, incontinence and overall quality of life. The test to implant rate of a traditional percutaneous procedure was 52%, compared to a staged procedure of 94%. Assessing sensory response at the time of implant reduced the reoperation rate from 43% to 0%. Ninety-six per cent stated they would undergo an implant again and recommend the therapy to a friend. We concluded that sacral nerve modulation can treat refractory IC symptoms. The response to therapy and the reoperation rate are dependent on the technique used to test and implant the device.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00192-003-1070-3DOI Listing

Publication Analysis

Top Keywords

refractory interstitial
8
interstitial cystitis
8
sacral nerve
8
nerve modulation
8
traditional percutaneous
8
staged procedure
8
test implant
8
reoperation rate
8
sacral neuromodulation
4
neuromodulation treatment
4

Similar Publications

Identification of clinical subgroups in anti-SRP positive immune-mediated necrotizing myopathy patients using cluster analysis.

Ther Adv Musculoskelet Dis

January 2025

Department of Rheumatology and Immunology, West China Hospital, Sichuan University, No. 37 Guoxue Alley, Chengdu, 610041, China.

Background: Anti-signal recognition particle immune-mediated necrotizing myopathy (anti-SRP IMNM) is a rare autoimmune disorder characterized by muscle weakness and necrosis. Identifying clinical subgroups within this patient population could facilitate the management of the disease.

Objectives: To identify distinct clinical subgroups of anti-SRP IMNM patients.

View Article and Find Full Text PDF

At present, the modification of palladium (Pd) catalysts is an important topic due to its potential to enhance catalytic performance and reduce catalyst costs. In this work, boron (B) and carbon (C) are interstitially doped into the subsurface of Pd to construct PdB and PdC catalysts. The adsorption properties of acetylene and ethylene, the mechanism of acetylene hydrogenation, and ethylene selectivity are studied based on density functional theory (DFT) calculations.

View Article and Find Full Text PDF

Background: Dermatomyositis is a chronic inflammatory condition affecting muscles and skin, often associated with an increased risk of cancer. Specific autoantibodies, including anti-TIF1 (Transcription Intermediary Factor 1), have been linked to this risk. We present a case of dermatomyositis in a male patient positive for anti-TIF1 antibodies, subsequently diagnosed with squamous cell carcinoma of the tonsil, a novel association not previously documented.

View Article and Find Full Text PDF

Treatment with infliximab and tacrolimus in steroid-refractory pneumonitis secondary to anti-HER2 therapy.

ESMO Open

January 2025

The Clatterbridge Cancer Centre NHS Foundation Trust, Liverpool; Department of Molecular and Clinical Cancer Medicine, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, UK. Electronic address:

View Article and Find Full Text PDF

Objectives: Robotic-assisted laser interstitial thermal therapy (LITT) is a minimally invasive method for ablating seizure foci and has gained prominence in epilepsy treatment. The use of robotic guidance in these procedures can minimize errors in probe placement, potentially leading to better clinical outcomes. In this meta-analysis, we assessed the accuracy, safety, and effectiveness of robot-assisted LITT for drug-resistant epilepsy.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!